Latest Strategic Partnership News

Corazon Mining has identified multiple high-grade gold intercepts beyond the existing 191,000 oz resource at its Chalice project, prompting a targeted drilling campaign starting Q3 2026 to test resource expansion potential.

Pilot Energy Limited and its subsidiaries have appointed voluntary administrators after failing to secure necessary funding or a strategic partner for their Cliff Head Carbon Storage Project. The company’s shares remain suspended on the ASX as administrators review options to preserve stakeholder value.

Star Minerals has begun mining at its Tumblegum South Gold Project with high-grade gold intercepts confirmed, while also expanding its footprint by securing a large new exploration project near Merredin in Western Australia.

EQ Resources reported FY26 tungsten production of 1,189 tonnes WO3 and is advancing major expansion projects at its Mt Carbine and Barruecopardo mines to more than triple output amid tightening global supply.

Neurotech International has secured FDA clearance for its Investigational New Drug application for NTI164, enabling clinical development in the US and advancing its global registration and commercialisation plans.

Latrobe Magnesium has secured a binding $16 million funding deal with Long State Investment to complete commissioning and expand its Demonstration Plant, marking a crucial step towards commercial magnesium metal production.

Magnum Mining has secured Jack Lifton, a globally recognised rare earth expert, to steer business development as it advances its Piracanjuba North drilling campaign in Brazil.

Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.

MyEco Group has finalised its operational overhaul, consolidating manufacturing in China and cutting fixed costs to sharpen its focus on sustainable packaging growth.

Tartana Minerals has received an unsolicited proposal from a global mining group offering a premium share placement and potential strategic partnership, but the board remains divided on the next steps.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.

Iceni Gold has extended the gold anomalous zone at its Guyer West target within the 14 Mile Well Project, revealing a larger geochemical footprint open along strike and showing parallels to the nearby Wild West trend.